The use of ACE2 receptor increasing medication at hospital admission and mortality rates in COVID-19 patiënts

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26336

Enrollment

400

Registered

2020-04-02

Start date

2020-03-18

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Clinical diagnosis of COVID-19 Intubation for mechanical respiratory support (including ECMO)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
mortality and end of mechanical respiratory support.	—

Contacts

Public ContactDiederik van Wijk

NWZ Alkmaar

DF.van.Wijk@nwz.nl088-085-7589

Outcome results